Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Foods Intl 1H Loss Y1.82B Vs Net Y229.00M
Pharma Foods International Co. Ltd. (2929.TO) Japan Half-Year Ended January 31 GROUP 2026 2025 Revenue Y32.44 bln Y29.86 bln Operating Profit (Y2.36 bln) Y623.00 mln Pretax Profit (Y2.44 bln) Y645.00 mln Net Profit (Y1.82 bln) Y229.00 mln Per share…
TrumpRx Is a Step Toward Making the Pharma Market Finally Work for America
The Trump administration's latest move appears to continue its promise to put America first. Americans have long paid the highest drug prices in the world, while patients in Europe and Canada receive the same medicines for a fraction of the cost.
The conditions are just right for this dividend-paying pharma stock as it mounts a comeback
When poring over charts this week I wanted to find a stock with low risk, a safe dividend and a potential reversal brewing. With every search I kept coming back to this one – Pfizer. It's a stock that has driven investors crazy over the…
/afaqs/media/media_files/2026/03/12/glp-2026-03-12-15-21-38.jpg)
India warns pharma firms against ads for weight-loss drugs
India's drug regulator has warned pharmaceutical companies against directly or indirectly advertising prescription weight-loss medicines, including GLP-1 drugs used to treat obesity and diabetes. In an advisory issued by the Central Drugs Standard…
Marco Pharma International's vision for 2045: Expanding impact without compromising principles
What does success look like in 2045 for a family-run natural medicine company that refuses to cut corners? Isaac Conyers IV thinks about that question often. The Director of Operations at Marco Pharma International carries a legacy that started the…
Obesity Drugmaker Zealand Plans New Boston Research Hub
Zealand Pharma A/S plans to open a new research facility in Boston, part of the obesity drugmaker's effort to expand its presence in the US. The Danish company will likely hire between 50 and 100 people at the new lab, Chief Executive Officer Adam…
Innate Pharma's (IPHA) Buy Rating Reaffirmed at BTIG Research
Innate Pharma (NASDAQ:IPHA - Get Free Report)'s stock had its 'buy' rating reissued by equities research analysts at BTIG Research in a note issued to investors on Thursday, Benzinga reports. They currently have a $8.00 target price on the stock.
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Time to Buy?
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) gapped up prior to trading on Thursday. The stock had previously closed at $39.79, but opened at $41.90. Zealand Pharma A/S shares last traded at $41.50, with a volume of 600 shares traded. A…
BTIG Research Reiterates 'Buy' Rating for Ascentage Pharma Group International (NASDAQ:AAPG)
Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report)'s stock had its 'buy' rating reiterated by analysts at BTIG Research in a research note issued to investors on Thursday, Benzinga reports. They presently have a $48.00 price…
Ascendis Pharma A/S $ASND Shares Bought by Atika Capital Management LLC
Atika Capital Management LLC grew its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 35.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,160 shares of the…
aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting
aTyr Pharma NASDAQ: ATYR CEO Sanjay Shukla outlined the company's strategy to develop new therapies for inflammation and fibrosis based on tRNA synthetase biology during a presentation at the Leerink Partners Global Healthcare Conference. Shukla…
Centre's advisory on weightloss drug promos rein in existing products, and the flood to come, say experts
As global drugmakers Novo Nordisk and Eli Lilly slug it out in the marketplace over their recently introduced weightloss and diabetes-linked obesity products – the Centre's strongly worded advisory on “so-called awareness…
You can't recall AI like a defective drug
At a recent AI summit in New Delhi, Sam Altman warned that early versions of superintelligence could arrive by 2028, that AI could be weaponized to create novel pathogens, and that democratic societies need to act before they are overtaken by the…
Inside the race to bring AI to the $1 trillion legal industry
Silicon Valley loves a rivalry, and right now one of its most closely watched showdowns is unfolding in an unlikely arena: corporate law. Harvey and Legora, two artificial-intelligence startups selling software to law firms, are jockeying for…
Should You Be Taking Peptides?
“Peptides” has fast become one of the biggest buzzwords in the wellness world. And they're likely to get even more public attention in the coming months and years. Peptides are simple compounds with two or more amino acids. In the…
Receive a Daily briefing on Pharma Industry News
Get Started